RiverVest Venture Partners focuses exclusively on life sciences, in particular in the medical device and biopharmaceutical industries. RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio return...Show all
Phone: 314-726-6700
101 South Hanley Road
Suite 1850
St. Louis, 63105
Missouri, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-05-30 | Smart Wires | Series E | $54.62M | 3x5 Special Opportunity Partners |
| 2017-12-13 | Allakos | Series B | $100M | 3x5 Special Opportunity Partners, Alta Partners, LifeSci Advisors, New Enterprise Associates, Partner Fund Management, Redmile Group, Roche Venture Fund, Rock Springs Capital, and Samsara BioCapital |
| 2017-08-15 | VentureMed Group | Series B | $15M | Endeavour Vision |
| 2017-08-01 | Amplyx Pharmaceuticals | Series C | $67M | Arix Bioscience, BioMed Ventures, Lundbeckfond Ventures, New Enterprise Associates, Pappas Ventures, and Sofinnova Ventures |
| 2017-04-24 | Lyric Pharmaceuticals | Series A - II | $6.4M | Third Point |
